News
- Author:
- Neil Osterweil
Publish date: October 1, 2019
BARCELONA – The PROfound trial shows that targeted therapy can be effective against metastatic castration-resistant prostate cancer bearing DNA rep...
News
- Author:
- Neil Osterweil
Publish date: September 29, 2019
BARCELONA – Nivolumab and low-dose ipilimumab improved survival of patients with untreated advanced non–small cell lung cancer regardless of PD-L1 ...
News
- Author:
- Neil Osterweil
Publish date: September 29, 2019
BARCELONA – Osimertinib is the first TKI to show a survival advantage over another in advanced non–small cell lung cancer, FLAURA investigators say...
News
- Author:
- Neil Osterweil
Publish date: September 28, 2019
BARCELONA – Men who underwent prostatectomy fared just as well with observation and salvage radiotherapy as with adjuvant radiotherapy.
News
- Author:
- Neil Osterweil
Publish date: September 19, 2019
Patients negative for disease on PET scans after two chemotherapy cycles fared better with consolidation radiotherapy.
News
- Author:
- Neil Osterweil
Publish date: September 13, 2019
Truncating mutations in PBRM1 are moderately linked to response to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma.
News
- Author:
- Neil Osterweil
Publish date: September 11, 2019
A patient with acute lymphoblastic leukemia (ALL) and HIV had a complete ALL remission after a CCR5-depleted HSPC...
News
- Author:
- Neil Osterweil
Publish date: September 11, 2019
Ten anticancer drugs in development target proteins that are not essential for the survival or growth of cancer cells, investigators caution.
News
- Author:
- Neil Osterweil
Publish date: September 5, 2019
Patients with HER2-mutated non–small cell lung cancer were more likely to develop brain metastases on therapy than patients with KRAS mutations.
News
- Author:
- Neil Osterweil
Publish date: August 30, 2019
Toxicity and disease control rates with proton-beam therapy to treat internal mammary nodes compared favorably with those of conventional radiation...
News
- Author:
- Neil Osterweil
Publish date: August 29, 2019
Patients randomized to tandem stem cell transplants after successful induction therapy had fewer events than patients assigned to single transplant...
News
- Author:
- Neil Osterweil
Publish date: August 29, 2019
Identification of targetable mutations and the advent of immune checkpoint inhibitors have improved outcomes for many patients.
News
- Author:
- Neil Osterweil
Publish date: August 27, 2019
LUGANO, SWITZERLAND – In patients younger than 65 years old, two cycles of ibrutinib and rituximab followed by four cycles of chemotherapy produced...
News
- Author:
- Neil Osterweil
Publish date: August 20, 2019
There were no significant differences in limb volume changes among overweight women with lymphedema 1 year after starting a lifestyle intervention....
News
- Author:
- Neil Osterweil
Publish date: August 19, 2019
Real-world data on NSCLC progression drawn from electronic charts correlated with overall survival.
